Abstract
The surgical management of high risk neuroblastoma has been highly debated over the last decade. Many surgeons attempt a near total resection of the tumor no matter how extensive, and others believe that partial resection is all that is required for local control. The high risk population is unique in neuroblastoma, as most of these patients are only cured with a combination of systemic therapies, radiation therapy, and surgery. Even with these extensive treatment regimens, survival does not approach 50% at 5 years, bringing into question the role of surgery in the management of these children. Recent data continues to suggest that extensive (>90%) resections may not change the outcomes of these children.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Shamberger RC, Allarde-Segundo A, Kozakewich HP, Grier HE. Surgical management of stage III and IV neuroblastoma: resection before or after chemotherapy. J Pediatr Surg. 1991;26:1113–7; discussion 1117–8.
Kiely EM. Radical surgery for abdominal neuroblastoma. Semin Surg Oncol. 1993;9:489–92.
Shorter NA, et al. The role of surgery in the management of stage IV neuroblastoma: a single institution study. Med Pediatr Oncol. 1995;24:287–91.
La Quaglia MP, et al. Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg. 1994;29:1162–5; discussion 1165–6.
Castel V, et al. The role of surgery in stage IV neuroblastoma. J Pediatr Surg. 2002;37:1574–8.
La Quaglia MP, et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg. 2004;39:412–7; discussion 412–7.
Adkins ES, et al. Efficacy of complete resection for high-risk neuroblastoma: a Children’s Cancer Group study. J Pediatr Surg. 2004;39:931–6.
McGregor LM, et al. The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children’s Research Hospital Experience. Cancer. 2005;104:2837–46.
Simon T, Häberle B, Hero B, von Schweinitz D, Berthold F. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol. 2013;31:752–8.
Mullassery D, Farrelly P, Losty PD. Does aggressive surgical resection improve survival in advanced stage 3 and 4 neuroblastoma? A systematic review and meta-analysis. Pediatr Hematol Oncol. 2014;31:703–16.
Fischer J, et al. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer. 2017;17:520.
von Allmen D, et al. Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma. J Clin Oncol. 2017;35:208–16.
Medary I, et al. Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery. Ann Surg Oncol. 1996;3:521–5.
Cecchetto G, et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol. 2005;23:8483–9.
Monclair T, et al. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. Pediatr Blood Cancer. 2015;62:1536–42.
Davidoff AM, et al. Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy. Pediatr Blood Cancer. 2005;44:158–62.
Brodeur GM, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988;6:1874–81.
Brodeur GM, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.
Eisenhauer EA, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;1990(45):228–47.
Bagatell R, et al. Assessment of primary site response in children with high-risk neuroblastoma: an international multicenter study. J Clin Oncol. 2016;34:740–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vasudevan, S.A., Nuchtern, J.G. (2020). Surgical Strategies for High Risk Neuroblastoma. In: Sarnacki, S., Pio, L. (eds) Neuroblastoma. Springer, Cham. https://doi.org/10.1007/978-3-030-18396-7_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-18396-7_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18395-0
Online ISBN: 978-3-030-18396-7
eBook Packages: MedicineMedicine (R0)